Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats
- PMID: 1690423
- DOI: 10.1097/00006676-199003000-00016
Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats
Abstract
We examined in male Sprague-Dawley rats the effects of nicotine at doses of 50 (0.31 mM) and 200 mg/L (1.23 mM) given for a period of 16 weeks on body weight gain, food and fluid intake, plasma CCK, glucose and insulin levels, amylase secretory responses of isolated pancreatic acinar cells to CCK-8 and carbachol, and histopathology (gross and light microscopy) of stomach and pancreas. These parameters were re-examined further in animals treated with nicotine at doses of 200 mg/L (1.23 mM) for 12 weeks and given tap water for an additional 4 weeks to evaluate the effects of nicotine withdrawal. Metabolic data suggest that decreases in body weight gain, food and fluid intake, and plasma levels of glucose and insulin by nicotine are dose dependent. Endocrinological studies showed that the plasma levels of CCK were significantly increased with nicotine but the amylase secretory response of pancreatic acinar cells was inhibited in response to CCK-8 and carbachol. Histopathologic data revealed that treatment of animals with a high dose of nicotine enhanced the appearance of numerous vacuoles in the pancreatic acinar cell cytoplasm. When the pancreatic acinar cell morphology was closely examined, it showed evidence of pyknotic nuclei and fusion of vacuoles. Prominent loss of gastric mucosal surface was found in nicotine-treated animals with gross microscopic evidence of bleeding ulcers. All of the metabolic parameters except body weight gain were reversed upon nicotine withdrawal. In addition, plasma CCK levels and pancreatic enzyme secretion were reversed upon nicotine withdrawal.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Inhibition of CCK or carbachol-stimulated amylase release by nicotine.Life Sci. 1989;45(22):2163-8. doi: 10.1016/0024-3205(89)90083-0. Life Sci. 1989. PMID: 2481202
-
Effect of chronic amylase inhibition on pancreatic growth and acinar cell secretory function in rats.Pancreas. 1998 Jul;17(1):50-6. doi: 10.1097/00006676-199807000-00006. Pancreas. 1998. PMID: 9667520
-
Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.Ann Clin Lab Sci. 2001 Oct;31(4):376-82. Ann Clin Lab Sci. 2001. PMID: 11688849
-
Effects of CCK on pancreatic function and morphology.Ann N Y Acad Sci. 1994 Mar 23;713:180-98. doi: 10.1111/j.1749-6632.1994.tb44065.x. Ann N Y Acad Sci. 1994. PMID: 8185159 Review.
-
Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.Gastroenterol Clin North Am. 1989 Dec;18(4):735-56. Gastroenterol Clin North Am. 1989. PMID: 2482253 Review.
Cited by
-
Nicotinic regulation of energy homeostasis.Nicotine Tob Res. 2012 Nov;14(11):1270-90. doi: 10.1093/ntr/nts159. Epub 2012 Sep 18. Nicotine Tob Res. 2012. PMID: 22990212 Free PMC article. Review.
-
The emerging role of smoking in the development of pancreatitis.Pancreatology. 2011;11(5):469-74. doi: 10.1159/000332196. Epub 2011 Oct 5. Pancreatology. 2011. PMID: 21986098 Free PMC article. Review.
-
Epidemiologic and Mechanistic Associations Between Smoking and Pancreatitis.Curr Treat Options Gastroenterol. 2015 Sep;13(3):332-46. doi: 10.1007/s11938-015-0056-9. Curr Treat Options Gastroenterol. 2015. PMID: 26109145 Free PMC article.
-
Effect of nicotine on exocytotic pancreatic secretory response: role of calcium signaling.Tob Induc Dis. 2013 Jan 18;11(1):1. doi: 10.1186/1617-9625-11-1. Tob Induc Dis. 2013. PMID: 23327436 Free PMC article.
-
Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.Int J Cancer. 2009 Jul 15;125(2):276-85. doi: 10.1002/ijc.24388. Int J Cancer. 2009. PMID: 19358273 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous